Healthcare

JNJ.N
PFE.N
MRK.N

UPDATE 1-Oregon resident hospitalized for possible Ebola virus infection

PORTLAND, Ore., Oct 31 - An Oregon woman being monitored for possible Ebola infection has been hospitalized after registering a high temperature, state health officials said on Friday.

6:39pm EDT

CHRONOLOGY-Worst Ebola outbreak on record tests global response

Oct 29 - Global health authorities are struggling to contain the world's worst Ebola epidemic since the disease was identified in 1976. The virus has killed more than 4,900 people. (Interactive graphic on Ebola: http://graphics.thomsonreuters.com/14/ebola/index.html) Here is a timeline of the outbreak: March 22: Guinea confirms a previously unidentified hemorrhagic fever, which killed more than 50 people, is Ebola. March 30: Liberia reports two Ebola cases; suspected

6:39pm EDT

U.S. Medicare sets new hospital, doctor payments for 2015

WASHINGTON, Oct 31 - The U.S. Medicare program's payment rate for hospital outpatient services will increase 2.3 percent in calendar year 2015, while the rate for ambulatory surgical services will rise 1.4 percent, the federal government announced on Friday.

Financials, 6:01pm EDT

Jefferies CEO, chairman take drug tests

Oct 31 - Jefferies Group LLC said on Friday Chief Executive Rich Handler, Chairman Brian Friedman and executives at its healthcare division were tested negative for drug usage, after one of its investment banking head was accused of drug abuse.

UPDATE 2-Canada imposes visa ban on three Ebola-hit countries

(Adds comment from Canadian opposition party, paragraphs 7-8)

5:06pm EDT
Healthcare
Johnson & Johnson $107.78 +0.69%
Pfizer Inc $29.95 +0.37%
Merck & Co Inc $57.94 +1.10%

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Renaissance Capital
$92.00
Provider: Thomson Reuters StreetEvents
$75.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.